Dose-reduction gemcitabine and S1 combination therapy in over 70 years old patients with unresectable pancreatic cancer

Autor:	Mamoru Watanabe, Satoshi Miyake, Naoaki Dan, Shinya Ooka, Toshihiko Nouchi, Hiroyuki Sakashita, Osamu Noguchi, Yoshinori Sakai, Makoto Tomita, Takahiro Kawamura
Rok vydání:	2016
Předmět:	Oncology Old patients Unresectable Pancreatic Cancer medicine.medical_specialty Combination therapy business.industry medicine.medical_treatment Hematology Gemcitabine Internal medicine Medicine business Reduction (orthopedic surgery) medicine.drug
Zdroj:	Annals of Oncology. 27:vii102-vii103
ISSN:	0923-7534
DOI:	10.1093/annonc/mdw523.041
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::b4394c35410ec5f7ade8de68ff4d7066 https://doi.org/10.1093/annonc/mdw523.041 Zobrazit plný text záznamu